Home › Research › Topics › alkaloids
alkaloids
3 studies tagged alkaloids, dated 2013-06-20 to 2018-04-10. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Analogous β-Carboline Alkaloids Harmaline and Harmine Ameliorate Scopolamine-Induced Cognition Dysfunction by Attenuating Acetylcholinesterase Activity, Oxidative Stress, and Inflammation in Mice 2018-04-10
- Plant alkaloids as drug leads for Alzheimer's disease 2015-07-26
- Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease 2013-06-20
Studies
3 studies carry this tag.
Date range
2013 to 2018
Top journals
- Frontiers in pharmacology 1
- Neurochemistry international 1
- The Journal of pharmacy and pharmacology 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
The analogous β-carboline alkaloids, harmaline (HAL) and harmine (HAR), possess a variety of biological properties, including acetylcholinesterase (AChE) inhibitory activity, antioxidant, anti-inflammatory, and many others, and have great potential for treating Alzheimer's disease (AD).
-
Alzheimer's disease (AD) is a neurodegenerative illness associated with dementia and is most prevalent among the elderly population.
-
The inhibition of acetylcholinesterase (AChE), the key enzyme in the breakdown of acetylcholine, is currently the main pharmacological strategy available for Alzheimer's disease (AD).